The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 23rd 2024
A recent study suggests ketamine can significantly improve symptoms of PTSD and OCD—but this is based on a review of an insufficient number of randomized controlled trials.
November 22nd 2024
November 14th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Children of Chemically Intolerant Mothers at Risk for Autism and ADHD
August 17th 2015Study results published in the July-August 2015 issue of the Journal of the American Board of Family Medicine suggest a potential association between maternal chemical intolerance and a diagnosis of attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) in their offspring.
Study Challenges Marijuana Use Linked to Several Conditions
August 17th 2015Regarding pulmonary and mental health, an emerging study has reported teen marijuana use is not associated to the development of several conditions including depression, psychosis, allergies, headaches, or high blood pressure.
New Treatment Option for Severe Depression Has Fewer Side Effects
August 13th 2015Australian research indicates that ultra-brief pulse stimulation is nearly as effective as standard electroconvulsive therapy (ECT) for the treatment of severe depression, but with substantially fewer cognitive side effects.
Impact of Genetic Variations on Schizophrenia Treatment Effectiveness
Safe, effective treatments for schizophrenia are well-established in the United States and worldwide, with several second-generation antipsychotics (SGAs) approved for use. But earlier schizophrenia studies have shown that several single nucleotide polymorphisms (SNPs) – the genetic variations that can underlie differences in susceptibility to disease – are overexpressed in Caucasian patients with schizophrenia but not in their Chinese counterparts, and vice versa.
Study Will Evaluate Bipolar Medication in Treating Borderline Personality Disorder
Borderline personality disorder (BPD) is challenging to diagnose and treat. As yet, there are no drugs currently licensed for BPD treatment. In fact, guidance from England's National Institute for Health and Care Excellence recommends that pharmacologic therapy not be used for patients with BPD at all. This is potentially troubling, because those patients typically experience rapid and extreme changes in mood, poor social functioning and have high rates of suicidal behavior.
Self-Management for Patients Suffering from Depression
Self-management for chronic or long-term conditions such as pain, diabetes, asthma, or arthritis is now a common part of long-term care. The same is not true for depression. At least, not yet. As clinicians learn more about depression, it has ceased to be viewed alongside other acute conditions and is now often thought of as chronic or long-term. Research shows that more than half of all people will have at least one further depressive episode after their first.
After House Passage 21st Century Cures Act Awaits Senate Approval
With funding meant to bolster basic research and help make advances for a variety of conditions the fate of the 21st Century Cure Act is anything but secure even after passage by the US House of Representatives.
Study Suggests New Tools for Early Detection of Dementia
Because there are many types of dementia, with many potential underlying causes, diagnosing it properly can be challenging. Two commonly used tests can return negative results for patients who have demonstrated abnormal cognitive test results or unexplained cognitive dysfunction.
New Evidence Added to Strong Connection Between Depression and Diabetes Outcomes
A study evaluating glycemic response following insulin initiation for type 2 diabetes mellitus found that patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline and higher HbA1c levels.
Presence of Multimorbidities Negatively Impacts Rheumatoid Arthritis Treatment
Patients suffering from rheumatoid arthritis frequently have comorbidities such as depression, asthma, cardiovascular events (including myocardial infarction and stroke), solid malignancies, and chronic obstructive pulmonary disease, among others.